Literature DB >> 27034403

Human mast cells capture, store, and release bioactive, exogenous IL-17A.

Troy Noordenbos1, Iris Blijdorp1, Sijia Chen1, Jan Stap2, Erik Mul3, Juan D Cañete4, Erik Lubberts5, Nataliya Yeremenko1, Dominique Baeten6.   

Abstract

IL-17A, a major proinflammatory cytokine, can be produced by a variety of leukocytes, but its exact cellular source in human inflammatory diseases remains incompletely understood. IL-17A protein is abundantly found in mast cells in human tissues, such as inflamed synovium, but surprisingly, mechanistic murine studies failed to demonstrate IL-17A production by mast cells. Here, we demonstrate that primary human tissue mast cells do not produce IL-17A themselves but actively capture exogenous IL-17A through receptor-mediated endocytosis. The exogenous IL-17A is stored in intracellular granules and can subsequently be released in a bioactive form. This novel mechanism confers to mast cells the capacity to steer IL-17A-mediated tissue inflammation by the rapid release of preformed cytokine. © Society for Leukocyte Biology.

Entities:  

Keywords:  mRNA expression; spondyloarthritis; uptake

Mesh:

Substances:

Year:  2016        PMID: 27034403     DOI: 10.1189/jlb.3HI1215-542R

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  27 in total

Review 1.  Recent advances in our understanding of mast cell activation - or should it be mast cell mediator disorders?

Authors:  Theoharis C Theoharides; Irene Tsilioni; Huali Ren
Journal:  Expert Rev Clin Immunol       Date:  2019-04-22       Impact factor: 4.473

Review 2.  Revisiting the gut-joint axis: links between gut inflammation and spondyloarthritis.

Authors:  Eric Gracey; Lars Vereecke; Dermot McGovern; Mareike Fröhling; Georg Schett; Silvio Danese; Martine De Vos; Filip Van den Bosch; Dirk Elewaut
Journal:  Nat Rev Rheumatol       Date:  2020-07-13       Impact factor: 20.543

Review 3.  Interleukin 17 Family Cytokines: Signaling Mechanisms, Biological Activities, and Therapeutic Implications.

Authors:  Leticia Monin; Sarah L Gaffen
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-04-02       Impact factor: 10.005

Review 4.  Unmet Needs in the Field of Psoriasis: Pathogenesis and Treatment.

Authors:  Wolf-Henning Boehncke; Nicolo Costantino Brembilla
Journal:  Clin Rev Allergy Immunol       Date:  2018-12       Impact factor: 8.667

Review 5.  [Pathogenesis of spondylarthritis : Relevance for treatment].

Authors:  J Sieper; D Poddubnyy
Journal:  Z Rheumatol       Date:  2020-02       Impact factor: 1.372

Review 6.  Recent Updates in the Immunopathology of Type 3 Immunity-Mediated Enthesitis.

Authors:  Akihiro Nakamura; Nigil Haroon
Journal:  Curr Rheumatol Rep       Date:  2021-04-24       Impact factor: 4.592

Review 7.  IL-17: overview and role in oral immunity and microbiome.

Authors:  L Abusleme; N M Moutsopoulos
Journal:  Oral Dis       Date:  2016-12-27       Impact factor: 3.511

Review 8.  Current Unmet Needs in Spondyloarthritis.

Authors:  Denis Poddubnyy; Joachim Sieper
Journal:  Curr Rheumatol Rep       Date:  2019-07-13       Impact factor: 4.592

Review 9.  Ankylosing spondylitis: an autoimmune or autoinflammatory disease?

Authors:  Daniele Mauro; Ranjeny Thomas; Giuliana Guggino; Rik Lories; Matthew A Brown; Francesco Ciccia
Journal:  Nat Rev Rheumatol       Date:  2021-06-10       Impact factor: 20.543

Review 10.  IL-17 in inflammatory skin diseases psoriasis and hidradenitis suppurativa.

Authors:  J M Fletcher; B Moran; A Petrasca; C M Smith
Journal:  Clin Exp Immunol       Date:  2020-06-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.